Overview

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions are safe and effective compared to placebo for the treatment of the signs and symptoms of dry eye syndrome.

Phase:

Phase 2

Details

Lead Sponsor:

Mitotech, SA

Collaborator:

ORA, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions